DrugPatentWatch Database Preview

Bionpharma Inc Company Profile

BIONPHARMA INC has twenty-four approved drugs.

There are five US patents protecting BIONPHARMA INC drugs.

There are nineteen patent family members on BIONPHARMA INC drugs in seventeen countries and twenty-four supplementary protection certificates in eleven countries.

International Patents:	19
US Patents:	5
Tradenames:	24
Ingredients:	21
NDAs:	24
Drug Master File Entries:	2
Patent Litigation for Bionpharma Inc:	See patent lawsuits for Bionpharma Inc

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bionpharma Inc	CLOBAZAM	clobazam	TABLET;ORAL	208825-002	Oct 22, 2018	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Bionpharma Inc	METHYLPHENIDATE HYDROCHLORIDE	methylphenidate hydrochloride	TABLET;ORAL	209753-003	Mar 2, 2018	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Bionpharma Inc	CLOBAZAM	clobazam	SUSPENSION;ORAL	208819-001	Oct 22, 2018	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Bionpharma Inc	DUTASTERIDE	dutasteride	CAPSULE;ORAL	200899-001	Nov 20, 2015	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Bionpharma Inc	PARICALCITOL	paricalcitol	CAPSULE;ORAL	202539-002	Mar 27, 2014	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Bionpharma Inc	NAPROXEN SODIUM	naproxen sodium	CAPSULE;ORAL	021920-001	Feb 17, 2006		OTC	Yes	Yes	10,028,925	➤ Sign Up	Y			➤ Sign Up
Bionpharma Inc	CLOBAZAM	clobazam	TABLET;ORAL	208825-001	Oct 22, 2018	AB	RX	No	No		➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bionpharma Inc	MIDOL LIQUID GELS	ibuprofen	CAPSULE;ORAL	021472-001	Oct 18, 2002	6,251,426	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
C/GB98/013	United Kingdom	➤ Sign Up	PRODUCT NAME: LOPERAMIDE HYDROCHLORIDE AND SIMETHICONE; REGISTERED: UK 00242/0314 19970923
00002	Netherlands	➤ Sign Up	PRODUCT NAME: DOFETILIDE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; REGISTRATION NO/DATE: EU/1/99/121/001 - EU/1/99/121/015 19991129
/2003	Austria	➤ Sign Up	PRODUCT NAME: DUTASTERIDE, GEGEBENENFALLS IN FORM EINES PHARMAZEUTISCH ANNEHMBAREN SOLVATES; NAT. REGISTRATION NO/DATE: 1-24844, 1-24845 20030217; FIRST REGISTRATION: SE 17871, 17872 20020719
00C/005	Belgium	➤ Sign Up	PRODUCT NAME: DOFETILIDE; REGISTRATION NO/DATE: EU/1/99/121/001 19991129
C0027	France	➤ Sign Up	PRODUCT NAME: BEXAROTENE; REGISTRATION NO/DATE: EU/1/01/178/001 20010329
00054	Netherlands	➤ Sign Up	PRODUCT NAME: BEXAROTENE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AAN- VAARDBAAR ZOUT OF IN DE VORM VAN EEN ESTER MET EEN HYDROXYVER- BINDING MET DE FORMULE R9OH, WAARIN R9 EEN; NAT. REGISTRATION NO/DATE: EU/1/01/178/001 20010329; FIRST REGISTRATION: EU/1/01/178/001 20010329
2012 00035	Denmark	➤ Sign Up	PRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.